Research Interests:
Research Interests:
We speculated that elevated admission cardiac troponin T (cTnT) could predict worse microvascular function in patients with ST-elevation myocardial infarction who are managed with emergency percutaneous coronary intervention. In 27... more
We speculated that elevated admission cardiac troponin T (cTnT) could predict worse microvascular function in patients with ST-elevation myocardial infarction who are managed with emergency percutaneous coronary intervention. In 27 patients with ST-elevation myocardial infarction, we obtained admission cTnT, angiography at the time of intervention, and cardiovascular magnetic resonance after 3 days. Elevated admission cTnT was associated with a higher corrected Thrombolysis In Myocardial Infarction frame count (P = 0.04) and with a trend toward worse myocardial blush grade at the end of the procedure (P = 0.069), indicating a higher degree of microvascular obstruction. This was confirmed by its correlation with the size of perfusion defect seen at first-pass cardiovascular magnetic resonance (rho = 0.42, P = 0.028). In contrast, admission cTnT did not correlate with the amount of muscle necrosis as seen by delayed-enhancement cardiovascular magnetic resonance (rho = 0.12, P = 0.55)....
Research Interests: Cardiology, Microcirculation, Treatment Outcome, Medicine, Cardiovascular Medicine, and 15 moreHumans, Internal Medicine, Female, Male, Patient Admission, Aged, Middle Aged, Myocardial Infarction, Retrospective Studies, Coronary Circulation, Predictive value of tests, Troponin T, Cohort Studies, Magnetic resonance angiography, and Recovery of Function
Research Interests: Cardiology, Medicine, Antioxidants, Humans, Internal Medicine, and 15 moreFemale, Male, Lipid peroxidation, Middle Aged, Myocardium, Group, Biological markers, Coronary Circulation, Antioxidant Capacity, Experimental Model, Coronary artery, Myocardial Ischemia, Cardiovascular medicine and haematology, Lipid peroxides, and Coronary Vessels
Research Interests: Inflammation, Confocal Microscopy, Medicine, Humans, Female, and 15 moreMale, Aged, Middle Aged, C reactive protein, Lipopolysaccharides, Adult, Monocytes, Public health systems and services research, Reference Values, Enzyme Linked Immunosorbent Assay, nuclear factor kappa B, Interleukin, Cardiovascular medicine and haematology, In Vitro Techniques, and Inflammation Mediators
Research Interests:
Research Interests:
Research Interests:
Research Interests: Cardiology, Apoptosis, Medicine, Humans, Female, and 15 moreDeoxyribonucleic Acid, Male, Statistical Significance, Early development, Protein structure, Aged, Middle Aged, Neutrophils, Public health systems and services research, Angina pectoris, Coronary Artery Disease, Reverse Transcriptase, Somatic Cells, Cardiovascular medicine and haematology, and Coronary Vessels
... and Filippo Crea Galiffa, Ada Giglio, Francesca Graziani, Luigi M. Biasucci, Salvatore Brugaletta, Tritarelli, Michela Narducci, Vincenzo Pazzano, Daniela Pedicino, Vincenzo A. Mara Campioni, Giovanna Liuzzo, Anna Severino, Simona... more
... and Filippo Crea Galiffa, Ada Giglio, Francesca Graziani, Luigi M. Biasucci, Salvatore Brugaletta, Tritarelli, Michela Narducci, Vincenzo Pazzano, Daniela Pedicino, Vincenzo A. Mara Campioni, Giovanna Liuzzo, Anna Severino, Simona Giubilato, Alessandra CORONARY ...
Research Interests:
Research Interests:
To evaluate the preoperative presence of C-reactive protein (CRP) and troponin T(hs-TnT) in patients with coronary artery disease (CAD) undergoing cardiopulmonary bypass (CPB) in order to better clarify the role of atrial inflammation... more
To evaluate the preoperative presence of C-reactive protein (CRP) and troponin T(hs-TnT) in patients with coronary artery disease (CAD) undergoing cardiopulmonary bypass (CPB) in order to better clarify the role of atrial inflammation and/or myocardial ischemia in the development of postoperative atrial fibrillation (POAF). Prospective, nonrandomized study. University hospital. Thirty-eight consecutive ischemic patients admitted to the authors' hospital for CAD undergoing elective on-pump coronary artery bypass grafting (CABG). Elective on-pump CABG. Peripheral blood samples were collected from all patients before and 24 hours after CABG to assess high sensitive (hs)-CRP and troponin T (hs-TnT) levels. The patients' heart rhythm was monitored by continuous ECG telemetry. Biopsies from the right atrial appendage were obtained at the beginning of the CABG procedure in order to perform immunohistochemistry for CRP and reverse transcription polymerase chain reaction for CRP mRNA expression. Fourteen patients out of 38 (36%) developed POAF. Atrial CRP was found in 31 patients (82%), 10 with POAF and 21 with sinus rhythm (71% v 87% respectively, p = ns). None of the atrial samples was positive for CRP mRNA. Atrial CRP did not correlate with serum hs-CRP levels and with occurrence of POAF, but with the incidence of diabetes (p = 0.010). Postoperative hs-TnT levels, but not hs-CRP levels, were identified as the only predictor of POAF occurrence (p = 0.016). In patients undergoing CABG, neither peripheral nor tissue preoperative CRP levels, but only postoperative hs-TnT levels, correlated with POAF, suggesting the primary role of an ischemic trigger of atrial fibrillation.
Research Interests: Inflammation, Medicine, Fibrinogen, Humans, Female, and 15 moreMale, Atrial Fibrillation, Length of Stay, Aged, Middle Aged, C reactive protein, Age Factors, Coronary Artery Disease, Intensive Care Units, Coronary artery bypass surgery, Logistic Models, Cardiopulmonary bypass, Cardiovascular medicine and haematology, leukocyte Count, and Heart atria
Purpose: To assess the effects of bariatric surgery (BS) on cardiac mass, volumes and function as compared to persistent morbid obesity. Although beneficial effects of weight loss on cardiac function have been reported, systematic studies... more
Purpose: To assess the effects of bariatric surgery (BS) on cardiac mass, volumes and function as compared to persistent morbid obesity. Although beneficial effects of weight loss on cardiac function have been reported, systematic studies on the effect of BS as compared to persistent morbid obesity are lacking. Methods: One-hundred morbidly obese patients (body mass index -BMI- 47.7±7 kg/m2) referred for BS prospectively underwent an echocardiogram: 65 underwent BS and 35 did not. Fifty-one operated and 29 non-operated patients underwent repeat imaging after 2 years. Results: Operated patients showed a significant decrease in weight and BMI paralleled by a significant reduction of left ventricular (LV) mass (from 222.9±52.2 to 207.7±50g) and LV end-diastolic and end-systolic volumes (LVEDV from 124.6±29.3 to 119.4±28.7 and LVESV from 55.3±16.5 to 49.4±15ml) and by a significant increase of LV ejection fraction (from 55.9±4.8 to 59.2±4.4%). In contrast, in non-operated patients LV mass (from 226.5±71.4 to 241.4±94.7g), volumes [LVEDV from 52.8±5.1 to 54.2±6.6 and LVESV from 32.1±3.5 to 34.9±6ml] significantly increased and ejection fraction deteriorated (from 57.1±5.1 to 54.7±7.4%). At multivariate analysis, BS was the only significant predictor of change in LV end-systolic volume while weight change predicted change in LV mass. Conclusions: In extreme obesity the sustained weight loss achieved with BS is associated to an improvement of cardiac structure and function, while persistent severe obesity is associated to progressive deterioration. These favorable cardiac effects associated to previously described positive metabolic effects make BS an attractive therapeutic option in this setting of patients.
Research Interests:
Research Interests: Cardiology, Flow Cytometry, Medicine, Linear models, Hematopoietic Stem Cells, and 15 moreProspective studies, Humans, Internal Medicine, Female, Male, Peptides, Bone marrow, Glycoproteins, Aged, Middle Aged, C reactive protein, Acute Coronary Syndrome, Benzimidazoles, Angiotensin Converting Enzyme Inhibitors, and Cardiovascular medicine and haematology
Intensive statin therapy can lower the risk of recurrence of major cardiac events in patients with acute coronary syndromes. This could be related to the ability of statins to increase levels of Endothelial Progenitor Cells (EPCs), which... more
Intensive statin therapy can lower the risk of recurrence of major cardiac events in patients with acute coronary syndromes. This could be related to the ability of statins to increase levels of Endothelial Progenitor Cells (EPCs), which were demonstrated to be favorably associated with a better prognosis and post-infarction left ventricular remodeling in patients with ischemic heart disease.
Research Interests: Cardiology, Comparative Study, Hematopoietic Stem Cells, Humans, Internal Medicine, and 15 moreEndothelial Cells, Left Ventricular Assist Device, Female, Male, Acute Myocardial Infarction, Aged, Acute Coronary Syndrome, Endothelial cell, Ischemic Heart Disease, Left Ventricular Function, Etalon, Combined Modality Therapy, Cell count, Left Ventricular, and Cardiovascular medicine and haematology
Thienopyridines have a well-established role in the treatment of coronary artery disease, especially in the setting of acute coronary syndromes and percutaneous coronary interventions. Ticlopidine, the first FDA-approved thienopyridine,... more
Thienopyridines have a well-established role in the treatment of coronary artery disease, especially in the setting of acute coronary syndromes and percutaneous coronary interventions. Ticlopidine, the first FDA-approved thienopyridine, was shown to be effective in reducing coronary events in high risk patients, but the original enthusiasm was hampered by concerns about its serious bone marrow toxicity. Clopidogrel a second generation thienopyridine with lesser side effects, is not only at least as effective as ticlopidine, but in combination with a low dose of aspirin, has been demonstrated to reduce the risk of major cardiovascular events in acute coronary syndrome patients in large-scale, randomised trials. Recent studies have highlighted major flaws in clopidogrel pharmacokinetics due to its delayed onset of action, and much attention has been devoted to the phenomenon of clopidogrel 'resistance'. Among the novel, third generation thienopyridines, prasugrel as compared to clopidogrel has demonstrated lower inter-patient response variability and a reduced incidence of ischaemic events, but at an increased risk of major bleeding. Currently, several studies are continuing to test new direct P2Y12 receptor antagonists, such as cangrelor and AZD6140, characterised by a faster reversal of platelet inhibition.
Research Interests:
Research Interests: Obesity, Inflammation, Medicine, Cardiovascular Risk, Italy, and 15 moreHumans, Internal Medicine, Female, Male, Body Mass Index, Clinical Sciences, European, Middle Aged, Immune system, Morbidity, Cardiovascular Risk Factor, Retrospective Studies, Cardiovascular Diseases, Risk Factors, and Radioimmunoassay
Research Interests: Medicine, Humans, Diabetes mellitus, Immunity, Female, and 13 moreMale, Risk factors, T lymphocytes, Aged, Middle Aged, Acute Coronary Syndrome, Analysis of Variance, Age Factors, Risk Factors, Type 2 Diabetes Mellitus, Case Control Studies, Disease Free Survival, and Cardiovascular medicine and haematology
Research Interests:
Research Interests:
Background— Diffuse coronary vascular inflammation is associated with acute coronary syndromes. However, it is unknown whether inflammation also occurs within the myocardium. Therefore, this study was aimed at assessing the presence of... more
Background— Diffuse coronary vascular inflammation is associated with acute coronary syndromes. However, it is unknown whether inflammation also occurs within the myocardium. Therefore, this study was aimed at assessing the presence of activated cells in unaffected remote myocardium of patients with acute myocardial infarction (AMI), in comparison to the peri-infarct region from the same cases, and in comparison to myocardial specimens from control hearts. Methods and Results— Sixteen patients dying 1 to 12 weeks after AMI and 16 control subjects were selected at autopsy. Myocardial specimens were taken at remote unaffected viable regions and at peri-infarct regions in cases with AMI. Confocal microscopy was performed to measure the number of activated cells (DR+), T-lymphocytes (CD3+), and activated T-lymphocytes (CD3+/DR+). Activated cells and activated T-lymphocytes were found in remote unaffected regions in 11 of 16 cases (69%), in peri-infarct zone in all cases (100%), and in n...
Research Interests: Cardiology, Inflammation, Medicine, Humans, Internal Medicine, and 15 moreFemale, Male, Myocarditis, Recurrence, Clinical Sciences, T lymphocytes, Aged, Immune system, Myocardial Infarction, Public health systems and services research, Circulation, Lymphocytes, Syndrome, Cardiovascular medicine and haematology, and Coronary Vessels
Background— Multiple complex stenoses, plaque fissures, and widespread coronary inflammation are common in acute coronary syndromes. A systemic cause of atherosclerotic plaque instability is also suggested by studies of ischemic... more
Background— Multiple complex stenoses, plaque fissures, and widespread coronary inflammation are common in acute coronary syndromes. A systemic cause of atherosclerotic plaque instability is also suggested by studies of ischemic cerebrovascular disease. We investigated the association between coronary and carotid plaque instability and the potential common causal role of inflammation. Methods and Results— The ultrasound characteristics of carotid plaques were evaluated retrospectively in patients scheduled for coronary bypass surgery, 181 with unstable and 92 with stable angina, and prospectively in a similar group of patients, 67 with unstable and 25 with stable angina, in whom serum C-reactive protein levels were also measured. The prevalence of carotid plaques was similar in the retrospective and prospective studies and >64% in both unstable and stable coronary patients. The prevalence of complex, presumably unstable carotid plaques was 23.2% in unstable versus 3.2% in stable ...
Research Interests: Inflammation, Medicine, Comorbidity, Prospective studies, Humans, and 15 moreInternal Medicine, Risk factors, Clinical Sciences, Aged, Prevalence, Middle Aged, C reactive protein, Public health systems and services research, Retrospective Studies, Angina pectoris, Circulation, Biological markers, Risk Factors, Carotid Artery, and Cardiovascular medicine and haematology
Research Interests: Atherosclerosis, Medicine, Humans, Female, Male, and 15 morePhenotype, Renal Function, Clinical Sciences, Aged, Middle Aged, Coronary Angiography, cystatin C, Prognosis, Biological markers, Ischemic Heart Disease, Coronary Artery Disease, Glomerular Filtration Rate, Severity of Illness Index, Cardiovascular Events, and Cardiovascular medicine and haematology
Research Interests:
Research Interests:
Research Interests:
Acute coronary syndromes (ACS) and chronic stable angina represent extremes of the clinical spectrum of coronary artery disease (CAD). It is unknown whether genetic determinants affect the first clinical manifestation of CAD. We evaluated... more
Acute coronary syndromes (ACS) and chronic stable angina represent extremes of the clinical spectrum of coronary artery disease (CAD). It is unknown whether genetic determinants affect the first clinical manifestation of CAD. We evaluated the role of the C(-260)T polymorphism in the promoter of the CD14-receptor gene, an important mediator of the inflammatory response to lipopolysaccharide. CD14 C(-260)T polymorphism was assessed in 100 patients with an acute presentation of CAD (group 1), 66 patients with stable presentation (group 2) and 88 healthy people (group 3); all patients were whites. In addition, baseline sCD14 plasma levels, and interleukin-6 production by circulating monocytes after in-vitro stimulation with lipopolysaccharide (1 ng/ml) were assessed. T/T homozygosis was more frequent in group 1 (36%, P < 0.001 versus others). Interleukin-6 production was higher in T/T homozygotes (median 4092.4; range 387-10 582 pg/ml) than in C/T heterozygotes (median 2442, range 40...
Research Interests: Risk assessment, Medicine, Cardiovascular Medicine, Humans, Internal Medicine, and 15 moreChronic Disease, Female, Male, Phenotype, Aged, Middle Aged, Acute Coronary Syndrome, Monocytes, Odds ratio, Angina pectoris, Risk Assessment, Coronary Artery Disease, Case Control Studies, Interleukin, and Gene frequency
Research Interests: Medicine and Circulation
Research Interests:
Abstract 550: Prognostic Significance of Evolving ST-Segment Depression on Admission and Early Repeat Electrocardiograms in Non-ST Elevation Acute Coronary Syndromes - Insights from the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitor (SYNERG...more
Research Interests:
Research Interests:
Research Interests: Genetics, Cardiology, Chlamydia pneumoniae, Multivariate Analysis, Humans, and 16 moreFemale, Male, Blood groups, Bacteria, Follow-up studies, Aged, Middle Aged, C reactive protein, Acute Coronary Syndrome, Myocardial Infarction, Public health systems and services research, Prognosis, Ischemic Heart Disease, Predictive value of tests, Unstable Angina, and Inflammatory response
Research Interests:
Research Interests:
Research Interests:
Coronary angioplasty and coronary artery bypass grafting (CABG) are both major techniques for the management of coronary artery disease, but CABG is associated with a lower incidence of repeat revascularization. Recent studies comparing... more
Coronary angioplasty and coronary artery bypass grafting (CABG) are both major techniques for the management of coronary artery disease, but CABG is associated with a lower incidence of repeat revascularization. Recent studies comparing angioplasty with stenting vs CABG have yielded conflicting results, with some suggesting improved survival with stenting, and others the opposite. We thus undertook a systematic overview of the randomized trials comparing stenting vs CABG in coronary artery disease. MEDLINE (January 1986-February 2003), ISI Current Contents, the Cochrane Controlled Trial Register, LILACS and the American Heart Association, American College of Cardiology, European Society of Cardiology, and Transcatheter Cardiovascular Therapeutics conference proceedings were among the databases we searched. Abstraction was performed in a non-blinded manner on pre-specified forms. The random-effect odds ratios for death, myocardial infarction, stroke, repeat revascularization, and symptomatic angina were computed for the longest available follow-up. Nine randomized trials (3283 patients, representing only 6% of all screened subjects) with an average follow-up of 28 months were included in the analysis, while four studies were excluded because they were still unpublished, ongoing, or with non-systematic stenting. No study used drug-eluting stents. The odds ratios for stenting vs CABG were 0.82 (95% confidence interval-CI 0.57-1.18, p = 0.3) for the occurrence of death, non-fatal myocardial infarction or stroke, 4.6 (95% CI 3.5-5.9, p &amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;lt; 0.00001) for repeat revascularization, and 2.3 (95% CI 1.8-2.8, p &amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;lt; 0.00001) for symptomatic angina. Heterogeneity tests were not statistically significant. The results of sensitivity analysis were similar even after stratification for single vessel, off-pump, single center or high-quality studies. Overall and event-free survival after conventional stenting for coronary artery disease are similar to those after CABG, but surgery is still associated with a significantly lower incidence of repeat revascularization and symptoms. The role of next-generation drug-eluting stents in widening the indications for stenting and overcoming restenosis will need to be assessed in future observational and randomized studies comparing stenting vs CABG.
Research Interests:
Research Interests:
Research Interests:
Since inflammation is believed to have a role in the pathogenesis of cardiovascular events, measurement of markers of inflammation has been proposed as a method to improve the prediction of the risk of these events. We conducted a... more
Since inflammation is believed to have a role in the pathogenesis of cardiovascular events, measurement of markers of inflammation has been proposed as a method to improve the prediction of the risk of these events. We conducted a prospective, nested case-control study among 28,263 apparently healthy postmenopausal women over a mean follow-up period of three years to assess the risk of cardiovascular events associated with base-line levels of markers of inflammation. The markers included high-sensitivity C-reactive protein (hs-CRP), serum amyloid A, interleukin-6, and soluble intercellular adhesion molecule type 1 (sICAM-1). We also studied homocysteine and a variety of lipid and lipoprotein measurements. Cardiovascular events were defined as death from coronary heart disease, nonfatal myocardial infarction or stroke, or the need for coronary-revascularization procedures. Of the 12 markers measured, hs-CRP was the strongest univariate predictor of the risk of cardiovascular events; the relative risk of events for women in the highest as compared with the lowest quartile for this marker was 4.4 (95 percent confidence interval, 2.2 to 8.9). Other markers significantly associated with the risk of cardiovascular events were serum amyloid A (relative risk for the highest as compared with the lowest quartile, 3.0), sICAM-1 (2.6), interleukin-6 (2.2), homocysteine (2.0), total cholesterol (2.4), LDL cholesterol (2.4), apolipoprotein B-100 (3.4), HDL cholesterol (0.3), and the ratio of total cholesterol to HDL cholesterol (3.4). Prediction models that incorporated markers of inflammation in addition to lipids were significantly better at predicting risk than models based on lipid levels alone (P&amp;amp;amp;amp;lt;0.001). The levels of hs-CRP and serum amyloid A were significant predictors of risk even in the subgroup of women with LDL cholesterol levels below 130 mg per deciliter (3.4 mmol per liter), the target for primary prevention established by the National Cholesterol Education Program. In multivariate analyses, the only plasma markers that independently predicted risk were hs-CRP (relative risk for the highest as compared with the lowest quartile, 1.5; 95 percent confidence interval, 1.1 to 2.1) and the ratio of total cholesterol to HDL cholesterol (relative risk, 1.4; 95 percent confidence interval, 1.1 to 1.9). The addition of the measurement of C-reactive protein to screening based on lipid levels may provide an improved method of identifying persons at risk for cardiovascular events.
Research Interests: Nursing, Risk, Inflammation, Cardiovascular disease, Lipids, and 15 moreApolipoproteins, Prospective studies, Humans, Female, Homocysteine, Middle Aged, C reactive protein, New England, Analysis of Variance, Prognosis, Cardiovascular Diseases, Biological markers, New England Journalof Medicine, Case Control Studies, and Interleukin
C-reactive protein (CRP), the prototypic acute phase reactant and a sensitive marker of inflammation, consistently predicts new coronary events, including myocardial infarction and death, in patients with ischemic heart disease. The data... more
C-reactive protein (CRP), the prototypic acute phase reactant and a sensitive marker of inflammation, consistently predicts new coronary events, including myocardial infarction and death, in patients with ischemic heart disease. The data are very consistent with regard to the long-term outcome, but in many studies are also significant for in-hospital events. The predictive value of CRP is, in the majority of the studies, independent of and additive to that of the troponins. Moreover recent data suggest that CRP may be a reliable marker of the risk of restenosis after percutaneous coronary interventions and that its levels can be modulated by statins. Taken together, all these data suggest that CRP, probably with different cut-offs, should be used as a marker of risk and as a guide to therapy in patients hospitalized for acute coronary syndromes and in outpatients suffering from ischemic heart disease.
Research Interests:
Research Interests:
Research Interests:
Apoptosis may represent an important pathophysiological mechanism causing progressive myocardiocyte loss and left ventricular dilation, even late after acute myocardial infarction (AMI). This review discusses the role of myocardial... more
Apoptosis may represent an important pathophysiological mechanism causing progressive myocardiocyte loss and left ventricular dilation, even late after acute myocardial infarction (AMI). This review discusses the role of myocardial apoptosis on the basis of findings from experimental studies in animals and from observational studies in humans with the purpose of assessing the clinical relevance, determinants and mechanisms of myocardial apoptosis and the potential therapeutic implications. A more profound understanding of the impact of myocardiocyte loss on prognosis and of the mechanisms involved may lead to an improved understanding of cardiac remodeling and possibly to an improved patient care. In fact, among the potential modulators of myocardial apoptosis, angiotensin-converting enzyme inhibitors and beta-adrenergic receptor blockers have already been shown to improve the prognosis and symptoms in patients with post-infarction heart failure, and a reduction in myocardial apoptosis could partly contribute to such a beneficial effect. Several other putative factors could also modulate myocardial apoptosis after AMI, and many are currently under intense investigation. In particular, the infarct-related artery patency late after AMI may be a major clinical determinant of myocardial apoptosis and clinical benefits deriving from an open artery (the &amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;quot;open-artery hypothesis&amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;quot;), such as a slowing down of the remodeling process and a reduced arrhythmic risk, could be due, at least in part, to a reduced apoptotic myocardiocyte loss.